Table 2.
B. subtilis mutL missense mutation | Human MLH1 missense mutation | No. of reported occurrences in humansb | Potential functionc |
---|---|---|---|
A17V | A21V | 6 | ATP binding |
G18A | G22A | 11 | ATP binding |
P24L | P28L | 32 | ATP hydrolysis |
E30A | E34A | 4 | ATP hydrolysis |
N34H | N38H | 8 | ATP hydrolysis |
S40A | S44A | 5 | ATP hydrolysis |
N60S | N64S | 20 | Unclear |
G63R | G67R | 74 | ATP binding |
K80E | K84E | 20 | ATP hydrolysis |
G94S | G98S | 8 | ATP binding |
S102R | S106R | 7 | ATP binding |
R176G | R182G | 14 | DNA binding |
G234V | G244V | 6 | DNA binding |
R256C | R265C | 53 | ATP binding |
A list of MLH1 mutations, the corresponding B. subtilis missense mutations, the reported incidence in HNPCC patients, and the possible MutL functions impaired by each mutation is shown.
The occurrence of each human MLH1 missense mutation was obtained from the International Society for Gastrointestinal Tumors (www.insight-group.org).